Literature DB >> 31407456

Childhood gastroparesis is a unique entity in need of further investigation.

Liz Febo-Rodriguez1, Bruno P Chumpitazi1, Robert J Shulman1.   

Abstract

BACKGROUND: Despite increasing knowledge regarding gastroparesis (GP) in adults, little is known regarding the incidence, prevalence, and natural history of childhood GP. Exacerbating the knowledge gap in pediatric GP is both the lack of normative data for gastric emptying scintigraphy in children and lack of GP-specific pediatric reported outcome measures.
PURPOSE: The aim of this article was to review the available literature on pediatric GP and identify similarities and differences with studies in adults. We performed a comprehensive search in MEDLINE and Google Scholar from inception to April 2019 for articles published in English using the following combination of keywords: gastroparesis, pediatric gastroparesis, outcomes, metoclopramide, erythromycin, domperidone, cisapride, and gastric neurostimulator. The limited available pediatric data, often retrospective, suggest marked differences between adult and pediatric GP in several aspects including etiology, concomitant co-morbidities (eg, psychiatric disorders), clinical symptom presentation, diagnostic evaluation, response to therapies, and clinical outcome. Further research in pediatric GP is needed and holds the promise to further elucidate the mechanisms of this disorder in children and lead to pediatric-focused therapies.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  gastric emptying; gastroparesis; motility; pediatric gastroenterology

Year:  2019        PMID: 31407456      PMCID: PMC7015769          DOI: 10.1111/nmo.13699

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  122 in total

1.  The effect of low-dose erythromycin on whole gastrointestinal transit time of preterm infants.

Authors:  C Costalos; V Gavrili; V Skouteri; A Gounaris
Journal:  Early Hum Dev       Date:  2001-12       Impact factor: 2.079

Review 2.  Botulinum Toxin Injection for Treatment of Gastroparesis.

Authors:  Trisha S Pasricha; Pankaj J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-09-28

Review 3.  Gastroparesis in children.

Authors:  Saleem Islam
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

4.  A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates.

Authors:  P S Reddy; A K Deorari; C S Bal; V K Paul; M Singh
Journal:  Indian Pediatr       Date:  2000-08       Impact factor: 1.411

5.  A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.

Authors:  J Oei; K Lui
Journal:  Acta Paediatr       Date:  2001-08       Impact factor: 2.299

6.  Botulinum toxin A for the treatment of delayed gastric emptying.

Authors:  Frank K Friedenberg; Amiya Palit; Henry P Parkman; Alexandra Hanlon; Deborah B Nelson
Journal:  Am J Gastroenterol       Date:  2007-12-05       Impact factor: 10.864

7.  Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.

Authors:  S Fiorucci; E Distrutti; G Bassotti; R Gerli; S Chiucchiù; C Betti; L Santucci; A Morelli
Journal:  Scand J Gastroenterol       Date:  1994-09       Impact factor: 2.423

8.  The rising cost of hospital care for children with gastroparesis: 2004-2013.

Authors:  P L Lu; M Moore-Clingenpeel; D Yacob; C Di Lorenzo; H M Mousa
Journal:  Neurogastroenterol Motil       Date:  2016-05-25       Impact factor: 3.598

9.  Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.

Authors:  D Silvers; M Kipnes; V Broadstone; D Patterson; E M Quigley; R McCallum; N K Leidy; C Farup; Y Liu; A Joslyn
Journal:  Clin Ther       Date:  1998 May-Jun       Impact factor: 3.393

10.  Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis.

Authors:  Madhusudan Grover; Simon J Gibbons; Asha A Nair; Cheryl E Bernard; Adeel S Zubair; Seth T Eisenman; Laura A Wilson; Laura Miriel; Pankaj J Pasricha; Henry P Parkman; Irene Sarosiek; Richard W McCallum; Kenneth L Koch; Thomas L Abell; William J Snape; Braden Kuo; Robert J Shulman; Travis J McKenzie; Todd A Kellogg; Michael L Kendrick; James Tonascia; Frank A Hamilton; Gianrico Farrugia
Journal:  BMC Med Genomics       Date:  2018-08-07       Impact factor: 3.063

View more
  4 in total

1.  Dietary Interventions for Gastroparesis: A Systematic Review.

Authors:  Debra Eseonu; Tanya Su; Keya Lee; Bruno P Chumpitazi; Robert J Shulman; Ruben Hernaez
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

2.  Meal-Induced Symptoms in Children with Dyspepsia-Relationships to Sex and the Presence of Gastroparesis.

Authors:  Liz Febo-Rodriguez; Bruno P Chumpitazi; Salma Musaad; Andrew C Sher; Robert J Shulman
Journal:  J Pediatr       Date:  2020-12-23       Impact factor: 4.406

3.  PedsQL™ Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods.

Authors:  James W Varni; Robert J Shulman; Mariella M Self; Liz Febo-Rodriguez; Heather Charron; Kent Williams; Sam Nurko; Rachel L Rosen; Bruno P Chumpitazi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-08-01       Impact factor: 3.288

4.  Clinical Characterization of Pediatric Gastroparesis Using a Four-hour Gastric Emptying Scintigraphy Standard.

Authors:  Sharon Wolfson; Zoe Wilhelm; Antone R Opekun; Robert Orth; Robert J Shulman; Bruno P Chumpitazi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-06-01       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.